Characteristics of patients with myelodysplastic neoplasm and spliceosome mutations

Leukemia. 2023 Jun;37(6):1397-1400. doi: 10.1038/s41375-023-01899-9. Epub 2023 Apr 25.

Authors

Affiliations

¹ Department of Cancer Medicine, MD Anderson Cancer Center, Houston, TX, USA.
² Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA.
³ Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA.
⁴ Department of Hematopathology, MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Leukemia, MD Anderson Cancer Center, Houston, TX, USA. ggarciam@mdanderson.org.

PMID: 37185307
DOI: 10.1038/s41375-023-01899-9

No abstract available

Publication types

Research Support, N.I.H., Extramural
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Mutation
Myelodysplastic Syndromes* / genetics
Neoplasms*
RNA Splicing / genetics
RNA Splicing Factors / genetics
RNA Splicing Factors / metabolism
Spliceosomes / genetics
Spliceosomes / metabolism

Substances

RNA Splicing Factors